Ratios (Summary)

Amgen Inc., liquidity ratios (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Current ratio 3.88 5.49 6.07 6.20 4.41 4.11 4.35 3.97 4.95 4.44 5.42 5.48 5.53 4.95 4.22 4.36 3.45 3.44 6.33 6.20 5.58
Quick ratio 3.42 4.98 5.46 5.47 3.96 3.68 3.90 3.52 4.44 3.97 4.75 4.76 4.68 4.22 3.56 3.67 2.72 2.78 5.32 5.16 4.63
Cash ratio 3.07 4.62 5.05 5.02 3.65 3.40 3.60 3.23 4.08 3.62 4.34 4.35 4.28 3.86 3.28 3.33 2.41 2.44 4.66 4.60 4.14
Source: Based on data from Amgen Inc. Quarterly and Annual Reports
Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Amgen Inc.'s current ratio deteriorated from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Amgen Inc.'s quick ratio deteriorated from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Amgen Inc.'s cash ratio deteriorated from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.

Top


Current Ratio

Amgen Inc., current ratio calculation (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Selected Financial Data (USD $ in millions)
Current assets 40,689  49,476  49,752  48,442  46,456  46,010  45,844  42,947  42,206  38,518  38,844  37,736  35,064  34,713  36,048  34,328  28,302  27,367  30,675  29,673  28,695 
Current liabilities 10,479  9,020  8,193  7,815  10,523  11,204  10,542  10,830  8,523  8,667  7,165  6,891  6,336  7,008  8,551  7,866  8,203  7,947  4,843  4,784  5,142 
Ratio
Current ratio1 3.88 5.49 6.07 6.20 4.41 4.11 4.35 3.97 4.95 4.44 5.42 5.48 5.53 4.95 4.22 4.36 3.45 3.44 6.33 6.20 5.58
Source: Based on data from Amgen Inc. Quarterly and Annual Reports

Q1 2018 Calculations

1 Current ratio = Current assets ÷ Current liabilities
= 40,689 ÷ 10,479 = 3.88

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Amgen Inc.'s current ratio deteriorated from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.

Top


Quick Ratio

Amgen Inc., quick ratio calculation (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Selected Financial Data (USD $ in millions)
Cash and cash equivalents 9,741  3,800  3,000  2,629  3,358  3,241  3,485  2,630  2,896  4,144  3,226  3,795  2,864  3,731  3,677  4,352  3,687  3,805  8,281  5,806  2,530 
Marketable securities 22,431  37,878  38,351  36,598  35,040  34,844  34,495  32,404  31,844  27,238  27,894  26,198  24,254  23,295  24,398  21,836  16,115  15,596  14,277  16,212  18,741 
Receivable from sale of investments 560 
Trade receivables, net 3,633  3,237  3,404  3,560  3,248  3,165  3,186  3,078  3,078  2,995  2,901  2,779  2,548  2,546  2,355  2,697  2,514  2,697  2,670  2,674  2,528 
Total quick assets 35,805  44,915  44,755  42,787  41,646  41,250  41,166  38,112  37,818  34,377  34,021  32,772  29,666  29,572  30,430  28,885  22,316  22,098  25,788  24,692  23,799 
Current liabilities 10,479  9,020  8,193  7,815  10,523  11,204  10,542  10,830  8,523  8,667  7,165  6,891  6,336  7,008  8,551  7,866  8,203  7,947  4,843  4,784  5,142 
Ratio
Quick ratio1 3.42 4.98 5.46 5.47 3.96 3.68 3.90 3.52 4.44 3.97 4.75 4.76 4.68 4.22 3.56 3.67 2.72 2.78 5.32 5.16 4.63
Source: Based on data from Amgen Inc. Quarterly and Annual Reports

Q1 2018 Calculations

1 Quick ratio = Total quick assets ÷ Current liabilities
= 35,805 ÷ 10,479 = 3.42

Ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Amgen Inc.'s quick ratio deteriorated from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.

Top


Cash Ratio

Amgen Inc., cash ratio calculation (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Selected Financial Data (USD $ in millions)
Cash and cash equivalents 9,741  3,800  3,000  2,629  3,358  3,241  3,485  2,630  2,896  4,144  3,226  3,795  2,864  3,731  3,677  4,352  3,687  3,805  8,281  5,806  2,530 
Marketable securities 22,431  37,878  38,351  36,598  35,040  34,844  34,495  32,404  31,844  27,238  27,894  26,198  24,254  23,295  24,398  21,836  16,115  15,596  14,277  16,212  18,741 
Total cash assets 32,172  41,678  41,351  39,227  38,398  38,085  37,980  35,034  34,740  31,382  31,120  29,993  27,118  27,026  28,075  26,188  19,802  19,401  22,558  22,018  21,271 
Current liabilities 10,479  9,020  8,193  7,815  10,523  11,204  10,542  10,830  8,523  8,667  7,165  6,891  6,336  7,008  8,551  7,866  8,203  7,947  4,843  4,784  5,142 
Ratio
Cash ratio1 3.07 4.62 5.05 5.02 3.65 3.40 3.60 3.23 4.08 3.62 4.34 4.35 4.28 3.86 3.28 3.33 2.41 2.44 4.66 4.60 4.14
Source: Based on data from Amgen Inc. Quarterly and Annual Reports

Q1 2018 Calculations

1 Cash ratio = Total cash assets ÷ Current liabilities
= 32,172 ÷ 10,479 = 3.07

Ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Amgen Inc.'s cash ratio deteriorated from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.

Top